In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Right ventricular free wall strain predicts low cardiac output syndrome in patients left ventricular ejection fraction >35% undergoing open aortic valve replacement.

Session Poster Session 6

Speaker Juan Francisco Fritche Salazar

Congress : ESC Congress 2018

  • Topic : valvular, myocardial, pericardial, pulmonary, congenital heart disease
  • Sub-topic : Valvular Heart Disease: Surgery
  • Session type : Poster Session
  • FP Number : P5472

Authors : H Rodriguez Zanella (Mexico City,MX), K Balderas-Munoz (Mexico City,MX), A Jordan-Rios (Mexico City,MX), JA Arias Godinez (Mexico City,MX), ME Ruiz Esparza (Mexico City,MX), LP Badano (Padua,IT), T Edvardsen (Oslo,NO), D Muraru (Padua,IT), E Surkova (London,GB), BA Gaxiola-Macias (Mexico City,MX), E Bucio-Reta (Mexico City,MX), F Baranda-Tovar (Mexico City,MX), JF Fritche-Salazar (Mexico City,MX)

H. Rodriguez Zanella1 , K. Balderas-Munoz1 , A. Jordan-Rios1 , J.A. Arias Godinez1 , M.E. Ruiz Esparza1 , L.P. Badano2 , T. Edvardsen3 , D. Muraru2 , E. Surkova4 , B.A. Gaxiola-Macias1 , E. Bucio-Reta1 , F. Baranda-Tovar1 , J.F. Fritche-Salazar1 , 1National Institute of Cardiology Ignacio Chavez, Echocardiography Laboratory - Mexico City - Mexico , 2University Hospital of Padova, Department of Cardiac, Thoracic and Vascular Sciences. - Padua - Italy , 3Oslo University Hospital - Oslo - Norway , 4Royal Brompton Hospital - London - United Kingdom ,

European Heart Journal ( 2018 ) 39 ( Supplement ), 1133

Background: Low cardiac output syndrome (LCOS) after surgical aortic valve replacement (SAVR) leads to increased mortality and health care related costs. Right ventricular free wall longitudinal strain (RVFWS) may be a risk factor in patients without severely reduced left ventricular ejection fraction (LVEF). All had LVEF >35%.

Purpose: To evaluate the role of RVFWS to predict the occurrence LCOS after surgical aortic valve replacement in patients without severely reduced LVEF.

Methods: We prospectively recruited patients with severe aortic stenosis, with class I indication for SAVR. Clinical, hemodynamic and echocardiographic data was collected. Conventional right ventricular function parameters and RVFWS were measured using speckle tracking echocardiography. Univariate and multivariate linear regression analysis was used to analyze variables related with the occurrence of LCOS.

Results: Eighty-one patients (63 years ±8 were included and LCOS occurred in 19 (23%). Patients with LCOS had more frequently diabetes (35.5 vs 10.5%, p=0.037), underwent more mitral valve replacement (3% vs 16%, p=0.046), had longer aortic clamping time (72 (85–116 min) vs 96 (79–136 min), p<0.0008), cardiopulmonary bypass time (99 (85–116 min) vs 120 (102–184 min) p<0.001), lower LV global longitudinal strain (GLS) (-17±4% vs 14±5%, p=0.001) and RVFWS (-14±4 vs -18±4%, p=0.0001). Interestingly LVEF (p=0.065), tricuspid annular plane systolic motion (p=0.28) right ventricular fractional area change (p=0.57) and right ventricular systolic pressure (p=0.062) did not differ. In the multivariate analysis, RVFWS was the only independent predictor of LCOS (Table). On ROC curve analysis a RVFWS with an absolute value lower than 15.1% had a sensitivity of 72% and a specificity of 79% (AUC=0.78) for LCOS occurrence.

Conclusions: RVFWS is a strong independent predictor of LCOS after aortic valve replacement in patients without severely reduced LVEF. RVFWS can improve risk stratification for LCOS in this patient subset. Future studies to confirm our findings are needed.

Multivariate linear logistic regression analysis for LCOS
VariableOdds Ratio (CI 95%)p value
Diabetes0.37 (0.05–2.69)0.32
Mitral valve replacement1.4 (0.09–20.5)0.80
CPB1.029 (0.95–1.07)0.44
Aortic clamping time1.12 (0.92–1.080.78
LV GLS1.046 (0.84–1.29)0.68
RVFWS1.49 (1.13–1.78)0.002

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are